IAM magazine
2014 IP Management Services
IAM magazine RSS feed IAM magazine on Twitter IAM magazine on Linked-in
Intellectual Asset Management
Subscriber login
Search

Ranking search

Keyword search

By country
Welcome to the online home of the IAM Patent 1000 2014

It is a pleasure to welcome you to the IAM Patent 1000 2014 The World’s Leading Patent Professionals, the third edition of our unique guide to leading private practice patent professionals and firms in 41 of the world’s key jurisdictions. To the best of our knowledge, the IAM Patent 1000 remains the only one-stop-shop guide exclusively dedicated to listing, and writing about, best-in-class patent prosecution, licensing and litigation practitioners on a global basis. In this edition, for the first time, we also take a look at expert witnesses, with a listing in the US section of the guide of leading individuals in this crucial area. All in all, therefore, what was already recognised as a vital source of information for those looking to identify market-leading patent expertise at both the individual and firm level has now become even more indispensable.  

Patents are now centre stage in a way that they have never been before. Whether it be major international litigations in the smartphone industry, portfolio purchases by social media businesses, the acquisition of companies in the pharmaceutical sector or the procurement of world-class software rights, incisive advice from lawyers and attorneys is now a must. The very best patent practitioners and firms combine in-depth knowledge of the legal process with the ability to understand the client’s business and what is at stake. They then use their insights to develop strategies tailored to the client which bring value far beyond the fees they charge. When playing for high stakes, such a skill-set is not a luxury; it is absolutely essential. Thus, the ability to locate the top individual practitioners, as well as attorney and law firms, which provide patent-related work to the highest standards is crucial. This is where the IAM Patent 1000 comes in.

Over a period of five months, a dedicated IAM research team based in London and Hong Kong conducted detailed interviews with hundreds of private practice lawyers and attorneys, as well as the users of their services, in countries across the world. The aim was to identify the practitioners and practices that companies turn to when only the best will do. In the United States, we also asked interviewees to name the expert witnesses they call on when they need world-class input on both damages and technical issues. The firms and individuals listed on the following pages are the results of that research.

All those listed in the IAM Patent 1000 are included because we received substantial positive feedback about them from multiple sources. We do not claim that we have managed to find every top name in every jurisdiction covered; but we are confident that we have included the vast majority, and that everybody who is named fully merits inclusion. A detailed methodology which explains the research process, as well as how our researchers decided who should finally be listed, can be found on page 3.

In addition to the editorial on leading practitioners and firms, you will find directories at the end of each country section (and the 18 regional sections and expert witness section in the United States), in which biographical details of some of the individuals listed are featured. Towards the end of certain sections, another directory also provides further information about some of the firms which are listed. All those who were selected for inclusion in the IAM Patent 1000 were offered the opportunity to publish this information for a fee – some decided that they wished to, while others declined. Inclusion in the editorial is in no way linked to this: the research was conducted entirely independent of any commercial considerations.

Joff Wild
Editor
Intellectual Asset Management

Featured firm

Kuhnen & Wacker Intellectual Property Law Firm

Kuhnen & Wacker (K&W) is a full-service IP law firm established more than 35 years ago in Freising, close to Munich airport. The firm represents small and medium-sized enterprises, as well as major corporate and global technical innovators. We have a fine blend of senior attorneys with sophisticated experience and younger proactive attorneys who can, if necessary, rely on the experience of their more senior colleagues.Continuity, quality and strategy have been the three pillars and principles of our nationally and internationally regarded IP firm since 1976. Based on these principles, K&W offers high-quality, proactive services at competitive rates.We have a diverse ... View full profile »

Featured lawyer

Bradford J Badke

Bradford J Badke

Partner - Ropes & Gray LLP

Bradford J Badke is an established lead trial counsel with numerous recent jury and bench trial victories in ‘bet the company’ IP cases in courtrooms across the country. His patent litigation successes for client Nova Biomedical, which faced formidable opposition from three leading life sciences companies, were highlighted in a prominent Forbes magazine article.Mr Badke has been featured as American Lawyer’s Litigator of the Week, and he and his team were ranked number one in the country’s Lawyers to the Innovators by the Financial Times in its US Innovative Lawyers Report for his successes in the landmark Therasense case. Mr Badke’s litigation ... View full biography »

Featured country

Canada

Canada

The evolution of the Canadian patent scene continues apace, with several key developments in 2013. In September Eli Lilly launched a C$500 million North America Free Trade Agreement suit against the government after two of its most lucrative patents were invalidated, alleging that it had lost over C$1 billion in revenues as a result of unpredictable and subjective court decisions. Consumer rights groups expressed concern over the move and practitioners are almost universally agreed that the suit is a major overreaction. Most patent litigation currently centres on pharmaceuticals, with the invalidation of Pfizer’s Viagra patent making front-page news last year. The ruling was ... View full rankings »